Fog Pharmaceuticals is based in Cambridge. It has raised $506M in total funding. Latest round: Series E.
Fog Pharmaceuticals is based in Cambridge. Fog Pharmaceuticals has raised $506M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series E announced in February 2024. The round record for Fog Pharmaceuticals runs through 2024; nothing later has been disclosed. Investors on record include 6 Dimensions Capital, GV, Blue Pool Capital, Horizons Ventures, Nan Fung Group, Leerink Partners. 6 distinct backers are named across the disclosed rounds.
Totals shown for Fog Pharmaceuticals aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026